HTS Reader Features Three Light Sources

Pharmaceutical Technology Editors;

Article

PTSM: Pharmaceutical Technology Sourcing and Management

November 30, 2015

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management-12-02-2015

Volume11

Issue 12

HTS Reader Features Three Light Sources

Author(s):

Pharmaceutical Technology Editors

BMG LABTECH announces the release of a new reference multi-mode HTS reader at SLAS in January 2016.

BMG LABTECH has announced the expected release of a reference multi-mode HTS reader, PheraStar FSX, in January 2016. The device performs non-isotopic detection technologies in plate formats up to 3456 plates. The optical design contains three independent light sources and a laser for time-resolved fluorometry (TRF) time-resolved fluorescence resonance energy transfer (TR-FRET) that completes 60 flashes per second.

For high-throughput screening, the PheraStar FSX includes robotic integration capabilities, multi-user control, MARS data analysis software, and FDA 21 CFR part 11 compliance.

BMG LABTECH will exhibit the microplate reader at the Society for Laboratory Automation and Screening Conference in San Diego, California on Jan. 23–27, 2016.

Source: BMG LABTECH

Articles in this issue

Software Corrects Spectra Data

Lab Reactor Designed for Scale-up

Instrument Measures Endotoxins at Point of Use

Instrument Manufacturers Collaborate on Interoperability

HTS Reader Features Three Light Sources

“A Hit for Every Target” and Changing the Model for Pharma Innovation

Researchers Identify Advances for Heterocyclic Chemistry

CMOs Lead Ongoing Drive for Single-Use Adoption

System Automates Traceability

Lufthansa Cargo Offers CSafe Containers

FDA Approves Ash Stevens as API Manufacturer for Takeda’s Multiple Myeloma Drug

Romaco Acquires Medipac AB and Extends Position in Effervescent Tablets Sector

Shimadzu’s Nexera UC Wins R&D 100 Award

Cobra Biologics to Scale Production of Growth Hormone

Pharma Supply Chains: Contingency Planning Not Yet a Priority, Survey Says

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!